Drug cuts breast cancer cases

19th December 2013

Taking the breast cancer drug anastrozole for five years reduced the chances of post-menopausal women at high risk of breast cancer developing the disease by 53% compared with women who took a placebo, according to a study published in the Lancet.

The results of the IBIS II trial, funded by Cancer Research UK and led by Queen Mary University of London, could offer a new option for preventing breast cancer in high risk post-menopausal women which is more effective than tamoxifen and has fewer side-effects.

Read article at source  worldpharmanews.com


Leave a Reply

Your email address will not be published.

17 − = 8

« back to posts